Epanova | AMRN Message Board Posts

Amarin Corporation plc

  AMRN website
  • Reminder to Premium Members: To enjoy full site functionality & avoid the bugs currently affecting recommend, delete & other features on our "www" pages, please log in to your premium accounts at https://premium.investorvillage.com If you need assistance, don't hesitate to contact customer support any time. That's a big part of what you pay for, after all!  


AMRN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  4402 of 4584  at  6/19/2019 12:36:53 PM  by

ex_hacker202


 In response to msg 4399 by  Sharon
view thread

Re: Epanova

  STRENGTH was "over powered" - too many patients and too short of a time spent in the trial - after R-IT results came out and showed max benefits occurred at later dates AZN extended the trial another year. Begs the question of if they'll greatly exceed the 1600 events needed and if that's ethical - only way they could extend a year and not exceed 1600 is if event rates are well below that seen in R-IT, which you'd think would be very unlikely - it would mean E has more efficacy the V, and nobody on earth expects that because of the DHA content in E.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 135
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
4403 Re: Epanova Public_Heel 5 6/19/2019 1:10:30 PM
4406 Re: Epanova Sharon 0 6/19/2019 2:23:05 PM


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...